Evidence map›Paper›PMID 33154065›Full record

ReviewBMJ open2020

Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project.

Miles D Witham, Eleanor Anderson, Camille B Carroll, Paul M Dark, Kim Down, Alistair S Hall, Joanna Knee, Eamonn R Maher, Rebecca H Maier, Gail A Mountain and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
10.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Exploring How Children and Young People With Sickle Cell Disease and Their Families Want to be Involved in Research: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2025
    Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Underserved 'Deep End' populations: a critical analysis addressing the power imbalance in research.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Miles D WithamNIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK miles.witham@newcastle.ac.uk.ORCID 0000-0002-1967-0990
Eleanor AndersonNIHR Clinical Research Network Cluster E, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Camille B CarrollFaculty of Health, University of Plymouth, Plymouth, Devon, UK.ORCID 0000-0001-7472-953X
Paul M DarkNIHR Manchester Biomedical Research Centre, The University of Manchester and Northern Care Alliance NHS Group, Manchester, UK.
Kim DownNIHR Clinical Research Network Cluster E, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Alistair S HallCardiology Department, Leeds General Infirmary Department of Cardiology, Leeds, West Yorkshire, UK.
Joanna KneeNIHR Clinical Research Network Coordinating Centre, University of Leeds, Leeds, West Yorkshire, UK.
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Rebecca H MaierNewcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Gail A MountainCentre for Applied Dementia Studies, University of Bradford, Bradford, West Yorkshire, UK.
Gary NestorNIHR Clinical Research Network Cluster E, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
John T O'BrienDepartment of Psychiatry, University of Cambridge, Cambridge, Cambridgeshire, UK.
Laurie OlivaNIHR Clinical Research Network Coordinating Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
James WasonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Lynn RochesterNIHR Clinical Research Network Cluster E, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
NIHR CRN INCLUDE Steering Group
NIHR Research Delivery Network · GBUniversity of Cambridge · GBGuy's and St Thomas' NHS Foundation Trust · GBLeeds General Infirmary · GBNewcastle University · GBNIHR Newcastle Biomedical Research Centre · GBUniversity of Bradford · GBUniversity of Leeds · GBUniversity of Manchester · GBUniversity of Plymouth · GB

Funding

Medical Research Council MC_UU_00002/6
6 · The paper itself

Abstract

objectiveTo provide guidance to researchers, funders, regulators and study delivery teams to ensure that research on COVID-19 is inclusive, particularly of groups disproportionately affected by COVID-19 and who may have been historically under-served by research. SUMMARY OF KEY POINTS: Groups who are disproportionately affected by COVID-19 include (but are not limited to) older people, people with multiple long-term conditions, people with disabilities, people from Black, Asian and Ethnic minority groups, people living with obesity, people who are socioeconomically deprived and people living in care homes. All these groups are under-served by clinical research, and there is an urgent need to rectify this if COVID-19 research is to deliver relevant evidence for these groups who are most in need. We provide a framework and checklists for addressing key issues when designing and delivering inclusive COVID-19 research, based on the National Institute for Health Research INnovations in CLinical trial design and delivery for the UnDEr-served project roadmap. Strong community engagement, codevelopment and prioritisation of research questions and interventions are essential. Under-served groups should be represented on funding panels and ethics committees, who should insist on the removal of barriers to participation. Exclusion criteria should be kept to a minimum; intervention delivery and outcome measurement should be simple, flexible and tailored to the needs of different groups, and local advice on the best way to reach and engage with under-served communities should be taken by study delivery teams. Data on characteristics that allow identification of under-served groups must be collected, analyses should include these data to enable subgroup comparisons and results should be shared with under-served groups at an early stage.

conclusionInclusive COVID-19 research is a necessity, not a luxury, if research is to benefit all the communities it seeks to serve. It requires close engagement with under-served groups and attention to aspects of study topic, design, delivery, analysis and dissemination across the research life cycle.

Indexed as

Minority GroupsSARS-CoV-2Biomedical ResearchCOVID-19HumansCOVID-19public healthstatistics & research methods

Identifiers

PMID33154065
PMCPMC7646322
OpenAlexW3093511019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.